Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 10:57 PM
Study NCT ID:
NCT01308567
Status:
COMPLETED
Last Update Posted:
2019-06-05
First Post:
2011-03-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-03
First Submit QC Date:
None
Study First Post Date:
2011-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-08
Results First Submit QC Date:
None
Results First Post Date:
2017-03-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-21
Last Update Post Date:
2019-06-05
Last Update Post Date Type:
ACTUAL